TNFSF10 and cancer: In vitro and in vivo findings presented in this study demonstrate the effectivity of novel local cancer immunotherapy, which connects the properties of fibrin, NKs and WJ-MSCs expressing the cytotoxic agent TRAIL (together FINM).